To study the effect of Duralabhadi Churna in vatik kasa(Dry cough)in childre

Phase 2

Conditions: Health Condition 1: R05- CoughHealth Condition 2: J00-J99- Diseases of the respiratory system

Registration Number: CTRI/2024/05/066800

Lead Sponsor: Dr Rukhsana Sheikh

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1)The patients having minimum 2 symptoms of Vatik Kasa are as follows-

1.The frequency of Kasa vega (Dry Cough)

2.Udarparshwa Shula (chest pain)

3.Swarbheda (Hoarseness of Voice)

4.Shukpurna Galasyata (Feeling Of Thorn Pricking in the Throat)

2) Patients between the ages of 1 year and 12 year.

3) The patients whose parents are ready to participate in the clinical trial by giving informed written consent.

Exclusion Criteria

1)Patients of other types of kasa (pittaj, kaphaj,

kshayaj, kshataj)

2)Patients having life threatening illness and who is bed ridden.

3)Patients having any congenital respiratory and

GIT abnormality.

4)Patients who require surgical management. 5)Patients having concomitant other systemic disorders like T.B., Bronchiolitis, Asthma, Pneumonia, Bronchiectasis, Lung abscess, Foreign body, pertussis etc.

6)Patient having complaint of fever or recent history of fever .

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in swarabheda & kasa vega after taking <br/ ><br> <br/ ><br> Duralabhadi Churna in the management of Vatik Kasa. <br/ ><br>Timepoint: 5 Days study with followup on 3rd and 5th day

Secondary Outcome Measures